Κατάλογος ενδεικτικών δημοσιεύσεων του τμήματος Ιατρικής ΑΠΘ σε διεθνή επιστημονικά περιοδικά κατά τα τελευταία 5 έτη.
Export 243 results:
Συντάκτης Τίτλος Τύπος [ Έτος] Φίλτρα: Συντάκτης is Kountouras, Jannis [Clear All Filters]
Cardio-cerebrovascular disease and Helicobacter pylori-related metabolic syndrome: We consider eradication therapy as a potential cardio-cerebrovascular prevention strategy..
Int J Cardiol. 229, 17-18.
(2017). Comment on "Effect of biofilm formation by clinical isolates of Helicobacter pylori on the efflux-mediated resistance to commonly used antibiotics"..
World J Gastroenterol. 23(33), 6194-6196.
(2017). Effects of combined low-dose spironolactone plus vitamin E vs vitamin E monotherapy on insulin resistance, non-invasive indices of steatosis and fibrosis, and adipokine levels in non-alcoholic fatty liver disease: a randomized controlled trial..
Diabetes Obes Metab. 19(12), 1805-1809.
(2017). A fully covered self-expandable metal stent anchored by a 10-Fr double pigtail plastic stent: an effective anti-migration technique..
Ann Gastroenterol. 30(1), 114-117.
(2017). Helicobacter pylori eradication to prevent cardio-cerebrovascular disease: Are current data useful for clinical practice?.
Int J Cardiol. 233, 92.
(2017). Helicobacter pylori on portal hypertension-related hepatic encephalopathy..
Immunopharmacol Immunotoxicol. 39(2), 105-106.
(2017). Helicobacter pylori-related chronic hepatitis C infection and the risk for cardiovascular disease..
Liver Int. 37(7), 1082.
(2017). Helicobacter pylori-related metabolic syndrome as predictor of progression to esophageal carcinoma in a subpopulation-based Barrett's esophagus cohort..
Gastrointest Endosc. 85(2), 462-463.
(2017). Impact of nitroglycerin and glucagon administration on selective common bile duct cannulation and prevention of post-ERCP pancreatitis..
Scand J Gastroenterol. 52(1), 50-55.
(2017). Impact of reactive oxygen species generation on Helicobacter pylori-related extragastric diseases: a hypothesis..
Free Radic Res. 51(1), 73-79.
(2017). Nonalcoholic fatty liver disease: Updates on associations with the metabolic syndrome and lipid profile and effects of treatment with PPAR-γ agonists..
Metabolism. 66, 64-68.
(2017). Novel aspects of defensins' involvement in virus-induced autoimmunity in the central nervous system..
Med Hypotheses. 102, 33-36.
(2017). Obesity and the nervous system: more questions..
Lancet Neurol. 16(10), 772-773.
(2017).
(2017).
(2017).
(2017). Activin A and follistatin in patients with nonalcoholic fatty liver disease..
Metabolism. 65(10), 1550-8.
(2016). Adipokines in nonalcoholic fatty liver disease..
Metabolism. 65(8), 1062-79.
(2016). Circulating leptin in non-alcoholic fatty liver disease: a systematic review and meta-analysis..
Diabetologia. 59(1), 30-43.
(2016). Circulating sclerostin and Dickkopf-1 levels in patients with nonalcoholic fatty liver disease..
J Bone Miner Metab. 34(4), 447-56.
(2016). Colchicine to decrease inflammation and fibrosis in patients with metabolic dysregulation..
Med Hypotheses. 95, 34.
(2016). Helicobacter pylori infection and oesophageal adenocarcinoma..
Cancer Epidemiol. 42, 206-7.
(2016). Hepatic encephalopathy (HE) due to intrahepatic portosystemic shunt after total gastrectomy..
Dig Liver Dis. 48(7), 825.
(2016). Homocysteine in nonalcoholic steatohepatitis: A reply..
Eur J Intern Med. 35, e40-e41.
(2016). A potential impact of Helicobacter pylori infection on minimal hepatic encephalopathy pathobiology..
J Gastrointestin Liver Dis. 25(3), 405-6.
(2016).